Terms: = Brain cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
6 results:
1. Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced cancer.
Owusuaa C; van der Padt-Pruijsten A; Drooger JC; Heijns JB; Dietvorst AM; Janssens-van Vliet ECJ; Nieboer D; Aerts JGJV; van der Heide A; van der Rijt CCD
JAMA Netw Open; 2022 Nov; 5(11):e2244350. PubMed ID: 36449290
[TBL] [Abstract] [Full Text] [Related]
2. The cbl-LSD1-CXCL8 axis regulates methionine metabolism in glioma.
Chang J; Wang L; Zhou X; Yuan J; Xu W
Cytokine; 2022 Mar; 151():155789. PubMed ID: 34998158
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract] [Full Text] [Related]
4. The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas.
Niu L; Feng WH; Duan CF; Liu YC; Liu JH; Liu XJ
Biomed Res Int; 2020; 2020():4630218. PubMed ID: 33163535
[TBL] [Abstract] [Full Text] [Related]
5. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering cancer Center experience.
Andersen BM; Miranda C; Hatzoglou V; DeAngelis LM; Miller AM
Neurology; 2019 May; 92(21):e2483-e2491. PubMed ID: 31019097
[TBL] [Abstract] [Full Text] [Related]
6. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
[TBL] [Abstract] [Full Text] [Related]
